Publications:
For the full list of publications, please visit
PubMed
1) Chua W, Law JP, Cardoso VR, Purmah Y, Neculau G, Jawad-Ul-Qamar M, Russell K, Turner A, Tull SP, Nehaj F, Brady P, Kastner P, Ziegler A, Gkoutos GV, Pavlovic D, Ferro CJ, Kirchhof P, Fabritz L. Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study. PLoS Med. 2021 Feb 3;18(2):e1003405. doi: 10.1371/journal.pmed.1003405. eCollection 2021 Feb.PMID: 33534825
2) Obergassel J, O'Reilly M, Sommerfeld LC, Kabir SN, O'Shea C, Syeda F, Eckardt L, Kirchhof P, Fabritz L. Effects of genetic background, sex, and age on murine atrial electrophysiology. Europace. 2021 Jun 7;23(6):958-969. doi: 10.1093/europace/euaa369.PMID: 33462602
3) Simon JN, Vrellaku B, Monterisi S, Chu SM, Rawlings N, Lomas O, Marchal GA,Waithe D, Syeda F, Gajendragadkar PR, Jayaram R, Sayeed R, Channon KM, Fabritz L, Swietach P, Zaccolo M, Eaton P, Casadei B. Oxidation of Protein Kinase A Regulatory Subunit PKARIα Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release. Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.046761. Epub ahead of print. PMID: 33185461.
4) Reyat JS, Chua W, Cardoso VR, Witten A, Kastner PM, Kabir SN, Sinner MF, Wesselink R, Holmes AP, Pavlovic D, Stoll M, Kääb S, Gkoutos GV, de Groot JR, Kirchhof P, Fabritz L. Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation. JCI insight 2020;5(16):e139179. https://doi.org/10.1172/jci.insight.139179.
5) Rathjens FS, Blenkle A, Iyer LM, Renger A, Syeda F, Noack C, Jungmann A, Dewenter M, Toischer K, El-Armouche A, Müller OJ, Fabritz L, Zimmermann WH, Zelarayan LC, Zafeiriou MP. Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control. Cardiovasc Res. 2020 Aug 10:cvaa239. doi: 10.1093/cvr/cvaa239. Online ahead of print. PMID: 32777030
6) Silbernagel N, Walecki M, Schafer MK-H, Kessler M, Zobeiri M , Rinné S, Kiper AK, Komadowski MA, Vowinkel KS, Wemhoner K, Fortmüller L, Schewe M, Dolga AM, Scekic-Zahirovic J, Matschke LA, Culmsee C, Baukrowitz T, Monassier L, Ullrich ND, Dupuis L, Just S, Budde T, Fabritz L & Decher N. The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel function. accepted 7 May 2018 FASEB journal PMID: 29879376 DOI:10.1096/fj.201800246R 30 Oct 2018 https://doi.org/10.1096/fj.201800246R
7) Chua W, Easter CL, Guasch E, Sitch A, Casadei B, Crijns HJGM, Haase D, Hatem S, Kääb S, Mont L, Schotten U, Sinner MF, Hemming K, Deeks JJ, Kirchhof P, Fabritz L. Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset. BMC Cardiovasc Disord. 2019 May 21;19:120.
8) Chua W, Purmah Y, Cardoso VR, Gkoutos GV, Tull SP, Neculau G, Thomas MR, Kotecha D, Lip GYH, Kirchhof P, Fabritz L. Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation, European Heart Journal, 2019;40:1268-76.
Review/Consensus/Editorial
1) Fabritz L, Crijns HJGM, Guasch E, Goette A, Häusler KG, Kotecha D, Lewalter T, Meyer C, Potpara TS, Rienstra M, Schnabel RB, Willems S, Breithardt G, Camm AJ, Chan A, Chua W, de Melis M, Dimopoulou C, Dobrev D, Easter C, Eckardt L, Haase D, Hatem S, Healey JS, Heijman J, Hohnloser SH, Huebner T, Ilyas BS, Isaacs A, Kutschka I, Leclercq C, Lip GYH, Marinelli EA, Merino JL, Mont L, Nabauer M, Oldgren J, Pürerfellner H, Ravens U, Savelieva I, Sinner MF, Sitch A, Smolnik R, Steffel J, Stein K, Stoll M, Svennberg E, Thomas D, Van Gelder IC, Vardar B, Wakili R, Wieloch M, Zeemering S, Ziegler PD, Heidbuchel H, Hindricks G, Schotten U, Kirchhof P. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace. 2021 Mar 8;23(3):329-344. doi:10.1093/europace/euaa279.PMID: 33555020
2) Fabritz L, Patten M, Kirchhof P. Taking the heavy load off arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2021 Jul;18(7):1192-1193. doi: 10.1016/j.hrthm.2021.04.011. Epub 2021 Apr 18.PMID: 33878457 (editorial)
3) Hendriks J, Fabritz L. AI can now identify atrial fibrillation through your sinus rhythm. The Lancet 2019 Lancet. 2019 Sep 7;394(10201):812-813. doi: 10.1016/S0140-6736(19)31719-2. Epub 2019 Aug 1. PMID:31378397 (editorial)
4) Fabritz L, Guasch E, Antoniades C, Bardinet I, Benninger G, Betts TR, Brand E, Breithardt G, Bucklar-Suchankova G, Camm J, Cartlidge D, Casadei B, Chua WWL, Crijns HJGM, Deeks J, Hatem S, Hidden-Lucet F, Kääb S, Maniadakis N, Martin S, Mont L, Reinecke H, Sinner M, Schotten U, Southwood T, Stoll M, Vardas P, Wakili R, West A, Ziegler A, Kirchhof P. Defining the Major Health Modifiers causing Atrial Fibrillation: A roadmap to underpin personalised prevention and treatment. Nature Reviews Cardiology, 2016 Apr;13(4):230-7.